o2h-ventures

Stemnovate’s compliant organs-on-chip platforms integrate stem cell research and tissue engineering to provide physiological alternative to cancer lines and animal models for precision drug discovery and screening.

Stemnovate is soon introducing the microfluidic platform for DNA synthesis
Status Active
Website https://stemnovate.co.uk/
Category Pharmaceutical Enabler
Modality Cell
Therapautics Area Multi Therapautics
Headquaters Cambridge, UK
Investment Portfolio Pre-Fund Investment
Co-Investors Business Angels, Innovate UK